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Iohexol has been successfully used as a marker to assess intestinal permeability in humans and 
various other mammals. The objective of this study was to evaluate the use of oral iohexol as an 
intestinal permeability marker in four anatomically and nutritionally diverse bird species. 
Methods  
Three dosages (1 ml/kg, 2 ml/kg, 4 ml/kg) of iohexol (755 mg/ml) were administered orally to 
each six clinically healthy pigeons and chickens at two-week intervals. Iohexol plasma 





concentration was determined 45, 90 and 180 min after administration. A comparative study 
was performed by administering iohexol twice to each six clinically healthy cockatiels and 
falcons, and determining iohexol plasma concentration at 45 or 90 min after administration.  
Results  
The recommended iohexol dosage for permeability testing in birds was determined to be 1 
ml/kg. Median plasma iohexol concentrations were 27.77 µg/ml in pigeons, 12.97 µg/ml in 
chickens, 14.24 µg/ml in cockatiels, and 47.81 µg/ml in falcons, 45 min after this dosage was 
administered. At 90 min after administration, median plasma iohexol concentrations were 40.68 
µg/ml in pigeons, 21.59 µg/ml in chickens, 32.03 µg/ml in cockatiels, and 55.96 µg/ml in falcons.  
Conclusions and clinical relevance 
Oral iohexol was a safe and feasible marker for intestinal permeability assessment in birds. 
Further investigations are warranted to establish species-specific reference intervals in larger 
numbers of healthy birds, and to examine the use of iohexol as a permeability marker in birds 
with disorders associated with altered intestinal permeability.  
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Intestinal permeability describes an important protective function of the gut wall: it prevents 
potentially harmful substances entering the body from the external environment, and only 
allows certain molecules to pass unimpeded through the intestinal mucosa.[1] The breakdown of 
intestinal mucosal integrity often leads to increased permeability of the gut, which is believed to 
play a critical role in initiating and developing various intestinal and non-intestinal diseases.[2] 
Some disorders often described in the context of altered intestinal permeability include 
inflammatory bowel disease (IBD), celiac disease, food allergies, as well as bacterial, viral and 
parasitic infections.[3–7] Measuring intestinal permeability can therefore be a valuable tool to 
help diagnose different diseases and to reveal in part their pathophysiology. The assessment of 
intestinal mucosal integrity has also been used to control the progression of disease during and 
after therapy, to evaluate the influence of drugs and toxic substances on intestinal permeability, 
and to detect a relapse of disease at an early stage.[5-10]  
Intestinal permeability can be measured non-invasively with an orally administered marker 
substance, such as lactulose and rhamnose, chromium 51-labeled ethylenediamine tetra-acetic 
acid (51Cr-EDTA), or iohexol. After a specific time period, the concentration of the recovered 
marker is measured in urine or blood. Normally the marker passes through the intestinal 
mucosa in a very restricted manner, but in conditions when the mucosa is damaged, markers can 
pass at higher concentrations. Although often claimed as inert molecules, sugar probes are 
partially metabolized by intestinal bacteria, making precise measurements unreliable.[11, 12] 
51Cr-EDTA is often considered as the ‘gold standard’ marker for intestinal permeability 
measurements, but its radioactivity is a major disadvantage, limiting its use in clinical 
practice.[12] Iohexol is a radiographic contrast medium that has been increasingly successful in 
its use as an intestinal permeability marker in humans and animals.[7, 9, 13, 14] Due to its 
metabolic stability, non-toxicity, water-solubility, passive absorption through the intestinal 





mucosa, and easy quantification, it shares many characteristics of an ideal intestinal 
permeability marker.[15]  
In avian species, iohexol has already been used as a safe and well-tolerated contrast medium, 
especially for radiographic studies of the gastrointestinal tract as well as to measure the 
glomerular filtration rate of the kidneys.[16-18] In birds, intestinal disorders as complex as IBD 
are rarely described, but evidence suggests that inflammatory conditions of the intestines in the 
form of chronic wasting disease exist in a similar pattern in avian species as they do in 
mammals.[19, 20] Furthermore, feed restriction or experimentally-induced enteropathies in 
poultry can disrupt the intestinal barrier function, resulting in an inflammation-mediated 
increase in intestinal permeability.[21-23]  
The purpose of this study was to evaluate the use of iohexol as a non-invasive permeability 
marker in healthy birds of four nutritionally diverse species, and to determine a recommended 
iohexol dosage for an intestinal permeability blood test after oral iohexol administration.  





Materials and Methods 
Animals  
Twenty four clinically healthy birds were included in this study. Specifically, we used six 
domestic pigeons (Columba livia forma domestica, age 3.5 to 5.5 years, 610 g ± 31 g), six laying 
hens (Gallus gallus forma domestica, age 1.5 to 2 years, 1987 g ± 90 g, breed Lohmann brown-
classic (Lohmann Tierzucht AG, Cuxhaven, Germany)), which are further referred to as chickens, 
six cockatiels (Nymphicus hollandicus, age 2 to 5 years, 105 g ± 4 g) and six falcons including four 
American kestrels (Falco sparverius, age 1.5 to 4.5 years, 100 g ± 9 g) and two Barbary falcons 
(Falco pelegrinoides, age 2 years, 531 g ± 123 g). All animals were adults, with an equal number 
of males and females, except for the group of chickens, which were all female. The pigeons, 
chickens and cockatiels were educational species owned and provided to the study by the Clinic 
for Birds and Reptiles of the University Leipzig, Germany. The two falcon species were privately 
owned by a falconer from Saxony, Germany. 
Housing and Husbandry  
The groups of pigeons, chickens and cockatiels were each housed in a large covered outdoor 
aviary with a shelter room protected from contact with wild birds and other study birds. The 
pigeons were fed with a seed and grain mix (Rassetaubenfutter Universal, mifuma GmbH, 
Mannheim, Germany), the chickens with a rough-cut grain variation (Geflügelfutter 
Vollkraftmehl, mifuma GmbH, Mannheim, Germany) and the cockatiels with a seed mixture for 
larger parakeets (Großsittichfutter, mifuma GmbH, Mannheim, Germany) supplemented with 
produce (fresh vegetables, herbs and fruits). The American kestrels were also housed in a large 
covered outdoor aviary with a shelter room. The Barbary falcons were tethered, with regular 
periods of free flight. Both falcon species were fed with mice and day-old chicks. The study was 
performed during early summer, with outdoor temperatures ranging from 18 °C to 22 °C during 





the day and 9 °C to 13 °C during the night. Daylight length ranged from 15:35 hours to 16:25 
hours.  
Ethical statement  
The study protocol was ethically approved by the Animal Care and Use Committee of the District 
Government of Saxony, Germany. All procedures were conducted in accordance with the 
national guidelines for research on animals. Written informed consent was obtained from the 
owner of the falcons prior to the study.  
Clinical examination  
The health status of all birds was determined with a thorough physical examination prior and 
during the experiment. Feces were examined by direct smear, flotation, sedimentation and 
cytology. Microbiologic examination of feces was done for Salmonella spp. on Brilliant-green 
phenol-red lactose sucrose-agar (BPLS) and Xylose Lactose Tergitol-agar (XLT4) (Oxoid GmbH, 
Wesel, Germany) after selective enrichment in Rappaport Vassiliadis broth (Oxoid GmbH, Wesel, 
Germany) over 24 hours ten days before the experiment started.  
Iohexol administration, sample collection and plasma analysis  
All birds were fasted before the study (pigeons for 4 hours; chickens for 6 hours; cockatiels for 2 
hours; falcons for 6 hours), to ensure the crop was empty before iohexol was administered 
orally. Water was freely accessible at any time prior to and during the study. Iohexol (755 mg/ml 
which corresponded to 350 mg of iodine/ml; Omnipaque-350, GE Healthcare AS, Oslo, Norway) 
was administered at variable doses as described below via a feeding tube inserted directly into 
the crop to ensure complete ingestion. The feeding tube was then flushed with a five-fold 
amount of isotonic saline solution (0.9 % Sodium Chloride) and removed. In pigeons, blood 
samples were taken from the ulnar vein; in chickens, cockatiels and falcons, blood samples were 
taken from the jugular vein (at a maximum 0.8 % of the body mass). Blood samples were 





obtained at pre-defined time intervals after the oral administration of iohexol, and stored in 
EDTA tubes (Sarstedt AG & Co. KG, Nümbrecht, Germany) at room temperature. About 30 
minutes (min) after the last blood sample was taken, all samples were centrifuged for six min at 
3250 g and the blood plasma was subsequently frozen at -20 °C. Storage time before analysis 
varied between 8 and 94 days (median 38 days). The plasma concentration of iohexol was 
determined by an enzyme-linked immunosorbent assay (ELISA) (FIT-GFR™ Kit (Iohexol), BioPAL 
Inc., Worcester, MA, USA) according to manufacturer’s instructions. This assay was recently 
validated for iohexol determination in canine plasma samples.[24] 
Determination of recommended iohexol dosage with pigeons and chickens 
The recommended iohexol dosage for the assessment of intestinal permeability in birds was 
determined by testing three different dosages in six healthy pigeons and six healthy chickens. 
Therefore, two animals of each species were always involved in a 2x3 Latin square design. At 
each sampling period – which occurred at two-week intervals – each animal received one of 
three different iohexol dosages (1.0, 2.0 and 4.0 ml/kg corresponding to 755, 1.510 and 3.020 
mg iohexol/kg body weight) in a fashion that every animal received every dosage once. Blood 
samples were taken 45, 90 and 180 min after oral iohexol administration, and plasma was 
analyzed for iohexol as described above. 
Comparative study with cockatiels and falcons 
We further analyzed six healthy cockatiels and six healthy falcons (American kestrels and 
Barbary falcons). Based on the results of the preliminary dose determination study (see above), 
1 ml/kg was selected as the recommended dosage for the iohexol permeability test. Oral 
administration was performed as described above. In cockatiels and Barbary falcons, blood was 
collected after 45 and 90 min. Two weeks later, the trial was repeated. In American kestrels, only 
one blood sample could be collected after oral iohexol administration. As such, a blood sample 





was collected after 45 min on the first trial day, and after 90 min on the second trial day (two 
weeks later). 
Data analysis 
All analyses were performed with commercially available statistical software (SPSS 23.0, SPSS 
Inc., Chicago, IL, USA; SAS® system 9.4, SAS Institute Inc., Cary, NC, USA). Descriptive statistics 
were generated. For pigeons and chickens, the species, doses and timepoints were compared 
with linear mixed effects model. Square-root transformation was used for the iohexol-
concentrations to satisfy the normality assumption. The linear mixed model included fixed 
effects for species (pigeon, chicken), timepoint (45, 90, 180) and dose (1 ml/kg, 2 ml/kg, 4 
ml/kg) together with two-way interactions of species*timepoint, species*dose and 
timepoint*dose. Each individual animal served as a random effect in the model. Pairwise 
differences between species (overall, and separately for each dose level), dose levels and time 
points were estimated from the model using least square means. The model fit was assessed by 
evaluating studentized model residuals graphically (normal QQ-plot) and by a test of normality 
(Kolmogorov-Smirnov test). Values of p < 0.05 were considered as statistically significant. 
The upper 95% and 99% confidence intervals were calculated to determine the cutoff point 
above which the iohexol plasma concentration would be significantly higher than concentrations 
after an oral iohexol dosage of 1 ml/kg, similar to a previous study performed on dogs.[25] 
Statistical analysis and calculation of the confidence intervals in cockatiels and falcons were not 









Clinical evaluation was normal for all birds at all times. Fecal examinations were negative for the 
presence of any endoparasites. Microbiological tests showed no evidence of Salmonella spp. 
Dose determination study 
After oral administration, iohexol plasma concentrations increased to highest levels at 180 min 
regardless of the species (with p-value of < 0.001 for the comparisons against both 45 min and 
90 min time point). Also, at 90 min post application the iohexol plasma concentration was higher 
than at 45 min (p=0.001). The maximum individual concentrations occurred at either 90 or 180 
min post application, both in pigeons and in chickens (Table 1).  
When comparing the two species over the three dose levels, pigeons were shown to have higher 
iohexol plasma concentration levels than chickens (p=0.032). This detected difference between 
species is similar with each of the three dose levels (p-value for the species*dose interaction 
0.461). However, the estimated difference between species, within dose level is statistically 
significant only at 4 ml/kg level (p=0.012). For the other two dose levels the difference between 
species was just above statistical significance (p=0.085 for both doses). 
As said, there was no interaction between species and dose level, thus the dose levels can be 
compared over the two species. The 4 ml/kg dosage was shown to have higher plasma iohexol 
concentration levels compared to the other two dosage levels 1 ml/kg, 2 ml/kg (p-values < 0.001 
and 0.022 respectively). There was no significant difference between the 1 ml/kg and 2 ml/kg 
dose levels (p=0.120). The highest individual iohexol plasma concentrations measured after 
application of 1/2/4 ml iohexol per kg were 79.79 µg/ml / 103.60 µg/ml and 203.70 µg/ml in a 
pigeon and 65.00 µg/ml / 132.80 µg/ml and 199.50 µg/ml in a chicken, all at 180 min. In 
summary, the measured iohexol plasma concentrations were higher in pigeons than in chickens 
and highest with the 4 ml/kg dose level compared to the other two dose levels (Figure 1). 
Adverse effects (watery droppings) were observed in two pigeons 120 min after the highest 





dosage (4 ml/kg) was administered. The dosage of 1 ml/kg iohexol was selected as 
recommended for permeability testing in the remaining birds. In chickens, values are 
significantly increased after 90 min when iohexol plasma concentration is above 31.51 µg/ml 
(95 %) or 37.41 µg/ml (99 %). In pigeons iohexol concentrations are significantly increased 
after 90 min when above 53.59 µg/ml (95 %) or 61.42 µg/ml (99 %). 
Comparative study 
In cockatiels and falcons, iohexol plasma concentrations showed the same trends as in pigeons 
and chickens: plasma levels increased up to 90 min after iohexol administration in most of the 
tested birds. One exception was a cockatiel (no. 2), in which the iohexol plasma level dropped 
from 8.64 µg/ml after 45 min to 6.63 µg/ml after 90 min on the second trial. A decrease in 
iohexol plasma concentration was also observed in a Barbary falcon (no. 5), where the iohexol 
plasma level dropped from 124.10 µg/ml after 45 min to 47.95 µg/ml after 90 min on the second 
trial (Table 2).  
The highest individual iohexol plasma concentration in cockatiels was 56.68 µg/ml 90 min after 
oral administration. In American kestrels, the highest plasma concentration measured was 
102.20 µg/ml after 90 min; in Barbary falcons, it was 134.5 µg/ml after 90 min. Some of the 
tested birds showed wide variation in iohexol plasma concentrations from one trial day to the 
other (cockatiel no. 1 at 90 min; falcon no. 5 at 45 and 90 min).  
Due to their small body size and problems with hematoma formation, it was only possible to 
obtain a single blood sample per trial day in the American kestrels – blood was sampled after 45 
min on the first trial day, and after 90 min on the second trial day. In this part of the study, no 
iohexol-related adverse effects were seen.  
 
Discussion 





The results of the present study indicate that upon oral administration, iohexol at a dosage of 1 
ml/kg is a safe and promising substance for non-invasive intestinal permeability blood tests in 
clinically healthy pigeons, chickens, cockatiels, American kestrels and Barbary falcons. A feeding 
tube was used for oral administration to ensure complete ingestion of the marker substance. 
This method is common in avian practice, as it is well-tolerated by the birds and does not 
require any sedation.[26] Drawing blood samples from birds is a relatively simple procedure, 
and considering that only a small amount of blood plasma or serum is needed for iohexol 
analysis with an ELISA, the method is suitable even for small avian species.[27] In mammals, it is 
common to measure recovery rates of permeability markers, typically in urine samples obtained 
in metabolic cages.[28] However, collecting urine samples is susceptible to fecal contamination 
in birds. Since birds lack a urinary bladder, the urine is held in the colon where it has contact 
with the feces. This can result in unnaturally high marker concentrations reported in 
(contaminated) urine when in fact most of the detected probe comes from the fecal matter, so 
that collecting pure urine samples while avoiding faecal contamination is difficult and probably 
not feasible in birds.[29, 30]  
To determine the recommended iohexol dosage for permeability testing, we chose three 
different dosages according to previous studies in mammals.[13, 25, 31] The dosage of 1 ml/kg 
was selected as suitable for permeability testing in birds because it allowed easy measurement 
and interpretation of iohexol concentrations in blood without causing any observable adverse 
effects in the animals. Furthermore, by keeping the administered volume as low as possible, it is 
less likely to cause problems with regurgitation or other unexpected adverse effects such as 
osmotic diarrhoea. To reduce the osmolality of the hyperosmolar iohexol solution and avoid 
osmotic diarrhoea, we additionally administered a five-fold volume of isotonic saline solution. 
However, at a dosage of 4 ml/kg some of the individuals experienced diarrhoea. Compared to 
similar studies in healthy dogs, the results in all four avian species were consistently higher, 
despite using the same dosage and similar time points for blood sampling.[25] A recent study 





revealed a strong correlation between results from ELISA and high-performance liquid 
chromatography (HPLC) methods in analysis of canine plasma.[24] Thus far, neither ELISA nor 
HPLC methods have been validated for iohexol detection in avian plasma. However, it is likely 
that a similar correlation would also exist between methods when measuring avian plasma, 
since iohexol is an inert and very stable molecule that is not metabolized in any species. To 
increase the reliability of our analyses, the ELISA was run with duplicate samples. The results of 
these samples were consistent between the analysis. Median plasma values varied between the 
different avian species after oral administration of 1 ml iohexol/kg body weight. Such 
differences in iohexol permeation and concentration could be a result of variation in 
nutrition/diet and/or the anatomy of the gastrointestinal tract of the species investigated here. 
For example, pigeons, belonging to the Columbiformes, only have vestigial caeca and are 
classified as a granivorous species. Chickens, which belong to the Galliformes, have fully-
developed caeca and are classified as omnivorous. Cockatiels are representatives of the 
Psittaciformes, and do not have caeca; they are classified as granivorous.[32, 33] American 
kestrels and Barbary falcons belong to the Falconiformes, and are carnivorous with only 
vestigial caeca.[34]  
The iohexol plasma values seem to be higher in falcons than in pigeons, chickens and cockatiels. 
One possible explanation could be physiological differences between carnivores (falcons) and 
granivores/omnivores (pigeons, chickens and cockatiels). Alternatively (or additionally), unlike 
the other birds in the study, the falcons were not accustomed to handling and physical restraint 
during oral administration and blood sampling, hence they likely experienced more stress 
during the procedures. Indeed, a study in rats described a positive correlation between the 
activity of the sympathetic nervous system (i.e. stress) and intestinal wall permeability.[35] 
Although American kestrels and Barbary falcons both belong to the same genus and have a 
similar diet and gastrointestinal anatomy, further studies are recommended to evaluate possible 
differences between these two falcon species.  





In the presence of intestinal damage, a higher amount of the permeability marker will pass 
through the gut-blood-barrier, resulting in higher iohexol concentrations in the blood. Compared 
to values reported in this study – which focused on healthy birds – significantly increased 
iohexol plasma concentrations would be expected in birds affected with certain gastrointestinal 
diseases. Future studies are needed to confirm this assumption. In particular, birds with signs of 
chronic wasting syndrome should be investigated to determine how this disorder affects 
intestinal permeability. Birds with other common disorders such as infections with 
Macrorhabdus ornithogaster or mycobacteria, parasites of the gastrointestinal tract, 
proventricular dilatation disease or gastrointestinal intoxications would also provide important 
insights about infection and permeability.  
In summary, we determined a recommended iohexol dosage for permeability testing in birds 
and made comparative studies in four nutritionally and anatomically different species. Due to 
the small number of animals analyzed in this trial, further studies are warranted to confirm the 
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Tables 
Table 1: Iohexol concentrations in plasma of pigeons and chickens after oral administration of 
three different dosages of Omnipaque-350. 
  Iohexol (µg/ml) 
 Dosage 1 ml/kg 2 ml/kg 4 ml/kg 
 Time  45 min  90 min  180 min  45 min  90 min  180 min  45 min  90 min  180 min  
Pigeon 1  16.24 28.81 20.16 23.66 32.80 103.60 31.50 79.59 175.20 
Pigeon 2 36.97 47.43 59.80 36.59 44.36 53.25 54.66 81.97 203.70 





Pigeon 3 32.13 52.95 79.79 39.44 36.50 67.83 37.27 48.84 123.60 
Pigeon 4 23.41 33.93 59.98 34.11 52.77 70.36 31.48 50.86 134.80 
Pigeon 5 44.51 53.21 34.31 34.46 56.93 66.30 23.71 30.54 52.72 
Pigeon 6 13.45 22.66 50.12 21.91 28.38 31.99 16.42 27.00 55.82 
Median  27.77 40.68 54.96 34.29 40.43 67.07 31.49 49.85 129.2 
Chicken 1  18.98 13.43 65.00 18.96 16.66 132.80 14.92 29.38 31.25 
Chicken 2 28.17 35.38 51.53 26.26 22.00 37.68 21.49 36.32 199.50 
Chicken 3 4.52 7.96 5.28 11.39 13.03 11.65 2.47 6.18 8.55 
Chicken 4 15.03 26.78 47.78 31.04 44.80 49.93 14.47 47.87 63.60 
Chicken 5 8.14 18.32 21.80 14.47 37.44 28.48 14.80 22.57 24.01 
Chicken 6 10.91 24.86 45.04 12.19 33.42 17.37 27.72 60.88 105.50 




Table 2: Iohexol concentrations in plasma of cockatiels and falcons (Falcons 1-4: American 
kestrels; falcons 5-6: Barbary falcons) after oral administration of 1 ml/kg Omnipaque-350. 
ND = not determined 
 
Iohexol (µg/ml) 





Time 45 min 90 min 
Trial  Day 1 Day 2  Day 1  Day 2  
Cockatiel 1  12.46 10.21 56.68 13.91 
Cockatiel 2 11.47 8.64 18.75 6.63 
Cockatiel 3 22.91 26.90 31.75 43.94 
Cockatiel 4 16.79 23.37 34.93 44.70 
Cockatiel 5 10.90 14.24 32.30 23.34 
Cockatiel 6 14.24 21.84 25.89 38.35 
Median 14.24 32.03 
Falcon 1 43.33 ND ND 19.30 
Falcon 2  99.37 ND ND  102.20 
Falcon 3  25.06 ND ND 44.62 
Falcon 4 22.92 ND ND 33.02 
Falcon 5 62.17 124.10 134.50 47.95 
Falcon 6 52.28 31.37 63.96 113.80 
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Figure 1: Iohexol plasma concentrations in pigeons and chickens using three different 
dosages of Omnipaque-350. 
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